BTG3 |
Q14201
|
BTG anti-proliferation factor 3
|
|
0.92 |
0.528 |
0.808 |
C3 |
P01024
|
complement C3
|
Enzyme modulator
|
0.90 |
0.445 |
0.885 |
COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
ISG20 |
Q96AZ6
|
interferon stimulated exonuclease gene 20
|
|
2.9E-03 |
0.414 |
0.846 |
MAPK1 |
P28482
|
mitogen-activated protein kinase 1
|
Kinase
|
1.00 |
0.330 |
0.923 |